Evidence map›Paper›PMID 41053879›Full record

ArticleBMC nutrition2025

Dietary inflammatory potential exacerbates sleep disturbances in hyperlipidemia: mediation by BMI and neuro-metabolic pathways.

Yueyu Zhang, Xinyi Chen, Yi Tang, Yu Wang, Kangrui Zhang, Juncang Wu

Abstract read
In one paragraph

Article in BMC nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yueyu Zhang *Department of Neurology, Hefei Hospital, Anhui Medical University (Hefei Second People's Hospital), Hefei, 230011, Anhui, People's Republic of China.
Xinyi Chen *Department of Neurology, Hefei Hospital, Anhui Medical University (Hefei Second People's Hospital), Hefei, 230011, Anhui, People's Republic of China.
Yi TangDepartment of Neurology, Hefei Hospital, Anhui Medical University (Hefei Second People's Hospital), Hefei, 230011, Anhui, People's Republic of China.
Yu WangDepartment of Neurology, Hefei Hospital, Anhui Medical University (Hefei Second People's Hospital), Hefei, 230011, Anhui, People's Republic of China.
Kangrui ZhangDepartment of Neurology, Hefei Hospital, Anhui Medical University (Hefei Second People's Hospital), Hefei, 230011, Anhui, People's Republic of China.
Juncang WuDepartment of Neurology, Hefei Hospital, Anhui Medical University (Hefei Second People's Hospital), Hefei, 230011, Anhui, People's Republic of China. wujuncang126@126.com.

Funding

Hefei Key Common Technology R&D"Projects (GJ2022SM07) GJ2022SM07Key Projects in Natural Sciences" Project (2024byzd401) 2024byzd401The Hospital - level Scientific Research Fund Project of Hefei Second People's Hospital" Project (2024ykc012) 2024ykc012
6 · The paper itself

Abstract

backgroundHyperlipidemia is closely associated with chronic low-grade inflammation and metabolic disorders. The Dietary Inflammatory Index (DII) reflects the pro-inflammatory potential of the diet, but its association with sleep disorders among individuals with hyperlipidemia remains unclear. This study aims to explore the association between DII and sleep disorders in adults with hyperlipidemia and analyze the mediating effect of body mass index (BMI).

methodsData from 13,195 participants with hyperlipidemia from the National Health and Nutrition Examination Survey (NHANES) in the United States (2007-2018) were included. Sleep disorders were defined based on self-reported physician diagnosis. DII scores were calculated based on 22 dietary components. Weighted multivariable logistic regression, restricted cubic splines, curve fitting models, and threshold analysis were used to evaluate the association between DII and sleep disorders. Finally, the mediating effect of BMI was analyzed.

resultsA total of 13,195 participants were included, of whom 1,598 reported sleep disorders. After adjusting for all covariates using weighted logistic regression, each 1-unit increase in DII was associated with a 5.7% higher prevalence of sleep disorders (odds ratio [OR] = 1.057, 95% confidence interval [CI]: 1.012-1.105). When DII was categorized into four groups, the OR for Q4 versus Q1 was 1.295 (95% CI: 1.039-1.614, P = 0.0269), with a significant trend (trend test P < 0.05). Restricted cubic spline and curve fitting models showed a linear relationship between DII and sleep disorder prevalence. Subgroup analysis indicated a stronger association between DII and sleep disorders among participants with hyperlipidemia who were under 60 years old. Mediation analysis further revealed that BMI mediated 26.07% of the association between DII and sleep disorders (P < 0.05).

conclusionThe results of this cross-sectional study show a positive association between pro-inflammatory diets and the risk of sleep disorders in patients with hyperlipidemia. A significant trend was observed across the quartiles of the Dietary Inflammatory Index (DII). The adjusted odds ratio (OR) for the highest quartile (Q4) compared with the lowest quartile (Q1) was 1.295 (95% confidence interval [CI]: 1.039-1.614, P = 0.0269), which was particularly evident in the young and middle-aged population (< 60 years old). Reducing the dietary inflammatory index may improve sleep health through weight loss (mediated by BMI) and direct anti-inflammatory effects. Future interventional studies are needed to clarify the causal impact of dietary inflammation regulation on sleep quality and the underlying molecular mechanisms, so as to provide a scientific basis for precision nutritional intervention.

Indexed as

Body mass indexDietary inflammatory indexHyperlipidemiaMediation effectSleep disturbances

Identifiers

PMID41053879
PMCPMC12502401

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.